Jannik Sinner's Path Forward After Positive Steroid Tests

Jannik Sinner's Case Overview

Top-ranked tennis player Jannik Sinner tested positive twice for a banned anabolic steroid in March and was stripped of prize money and points earned at a tournament in Indian Wells, California. But he will not be suspended because an independent tribunal said it was not intentional. The International Tennis Integrity Agency announced the case on Tuesday.

Sinner's Recent Achievements

Sinner won the Cincinnati Open on Monday and will be among the favorites at the U.S. Open, which starts in New York next week. He made his debut at No. 1 in the ATP rankings in June and is considered among the top stars of the new generation in men's tennis, along with Carlos Alcaraz.

Previous Performance and Setbacks

• Jannik Sinner, an Italian who turned 23 on Friday, won the Australian Open in January for his first Grand Slam title.
• He reached the semifinals at the French Open in June.
• Quarterfinalist at Wimbledon in July.
• He had to sit out of the Paris Olympics due to tonsillitis.

The Steroid Incident

During the Indian Wells hard-court event in March, Sinner tested positive for low levels of a metabolite of Clostebol, a banned anabolic steroid. Clostebol can be used for ophthalmological and dermatological use. This is the same drug that caused MLB star Fernando Tatis Jr. to be suspended.

Sinner tested positive again eight days later in an out-of-competition sample. In a statement provided to CBS News, Sinner's team emphasized that the positive tests were not indicative of intentional doping.